Longitudinal Tracking of Lung Cancer Clonal Dynamics using Circulating Tumour DNA

Thursday, January 28, 2027 at 4:40 PM to 5:10 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 2 - Thursday 28th January
CancerDiagnosticsLiquid Biopsy

Information

  • Cancer dynamics can be accurately tracked using circulating tumour DNA, overcoming limitations of sampling bias associated with biopsies  
  • We development a method to do this when the fraction of DNA in the blood from the tumour is extremely low (<0.1%), as is common, called ECLIPSE 
  • ECLIPSE reveals more complex metastatic patterns than previously appreciated, associated with outcome 
  • ECLIPSE reveals clonal dynamics in response to therapy, which are particularly common in immunotherapy treatment, suggesting as yet undiscovered resistance mechanisms.